Dr Rakesh Kanipakam, MD | |
5333 Mcauley Dr Rm 4003, Ypsilanti, MI 48197-1099 | |
(734) 712-3470 | |
Not Available |
Full Name | Dr Rakesh Kanipakam |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 11 Years |
Location | 5333 Mcauley Dr Rm 4003, Ypsilanti, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295197705 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Pcd Elmore County | Wetumpka, AL | Dialysis facility |
Baptist Medical Center South | Montgomery, AL | Hospital |
Baptist Medical Center East | Montgomery, AL | Hospital |
Prattville Baptist Hospital | Prattville, AL | Hospital |
Jackson Hospital & Clinic Inc | Montgomery, AL | Hospital |
Promedica Monroe Regional Hospital | Monroe, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Montgomery Kidney Specialists Llp | 0345220224 | 9 |
News Archive
New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health outcomes for patients with inherited bleeding and immune disorders as well as some forms of blood cancer.
Gleevec, a drug regarded by many as having "wonder drug" capabilities in the treatment of chronic myelogenous leukaemia (CML) and other cancers, has been revealed as having shortcomings in that some patients have undergone a relapse after building a resistance to the drug. For others with the advanced stage of the disease, the drug has failed to produce durable remissions.
Children and teens with attention-deficit/hyperactivity disorder (ADHD) who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms compared to those who received placebo, according to a study in the June 11 issue of JAMA, the Journal of the American Medical Association.
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
Women with preeclampsia, a common complication of pregnancy, face a heightened risk of stroke during pregnancy and postpartum if they have urinary tract infections, chronic high blood pressure, or clotting or bleeding disorders, according to a study by Columbia University Medical Center and NewYork-Presbyterian researchers.
› Verified 8 days ago
Entity Name | Montgomery Kidney Specialists Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356452403 PECOS PAC ID: 0345220224 Enrollment ID: O20040721001413 |
News Archive
New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health outcomes for patients with inherited bleeding and immune disorders as well as some forms of blood cancer.
Gleevec, a drug regarded by many as having "wonder drug" capabilities in the treatment of chronic myelogenous leukaemia (CML) and other cancers, has been revealed as having shortcomings in that some patients have undergone a relapse after building a resistance to the drug. For others with the advanced stage of the disease, the drug has failed to produce durable remissions.
Children and teens with attention-deficit/hyperactivity disorder (ADHD) who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms compared to those who received placebo, according to a study in the June 11 issue of JAMA, the Journal of the American Medical Association.
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
Women with preeclampsia, a common complication of pregnancy, face a heightened risk of stroke during pregnancy and postpartum if they have urinary tract infections, chronic high blood pressure, or clotting or bleeding disorders, according to a study by Columbia University Medical Center and NewYork-Presbyterian researchers.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rakesh Kanipakam, MD 5333 Mcauley Dr Rm 4003, Ypsilanti, MI 48197-1099 Ph: (734) 712-3470 | Dr Rakesh Kanipakam, MD 5333 Mcauley Dr Rm 4003, Ypsilanti, MI 48197-1099 Ph: (734) 712-3470 |
News Archive
New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health outcomes for patients with inherited bleeding and immune disorders as well as some forms of blood cancer.
Gleevec, a drug regarded by many as having "wonder drug" capabilities in the treatment of chronic myelogenous leukaemia (CML) and other cancers, has been revealed as having shortcomings in that some patients have undergone a relapse after building a resistance to the drug. For others with the advanced stage of the disease, the drug has failed to produce durable remissions.
Children and teens with attention-deficit/hyperactivity disorder (ADHD) who were treated with the herb St. John's wort did not have any greater improvement in ADHD symptoms compared to those who received placebo, according to a study in the June 11 issue of JAMA, the Journal of the American Medical Association.
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
Women with preeclampsia, a common complication of pregnancy, face a heightened risk of stroke during pregnancy and postpartum if they have urinary tract infections, chronic high blood pressure, or clotting or bleeding disorders, according to a study by Columbia University Medical Center and NewYork-Presbyterian researchers.
› Verified 8 days ago
Bretton Lee Schloesser, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Dr. Kelly Perry Apple, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 Fax: 734-712-3855 | |
Rajiv Doddamani, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197 Phone: 734-834-4270 | |
Dr. James Paolo Purtell, MD Nephrology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197 Phone: 734-712-5552 | |
Kory Ashton Strong, DO Nephrology Medicare: Medicare Enrolled Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Michael Sanson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-1300 Fax: 734-222-3665 | |
Dr. Stephanie Joy-kraftson Hoffman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197 Phone: 734-712-1000 Fax: 734-712-1012 |